Can prostate cancer be prevented? (Q36395066)

13 August 2017

1 reference

title

Can prostate cancer be prevented? (English)

1 reference

13 August 2017

1 reference

Eric A Klein

1

1 reference

PubMed ID

16474573

13 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

13 August 2017

Nature Reviews Urology

1 reference

13 August 2017

2

1 reference

13 August 2017

1

1 reference

13 August 2017

24-31

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro0072

13 August 2017

0 references

cites work

Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

Update on chemoprevention of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Burden of illness in cancer survivors: findings from a population-based national sample.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Prevention of prostate cancer with finasteride: US/European perspective

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

The influence of prostate size on cancer detection

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1).

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

The end of an era? Study reveals harms of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Selenium: epidemiology and basic science

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Prostatic and peripheral blood selenium levels after oral supplementation

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

The selenium and vitamin E cancer prevention trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Diet and its preventive role in prostatic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Plasma concentrations of phyto-oestrogens in Japanese men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Molecular targets for green tea in prostate cancer prevention

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Cyclooxygenase-2 and prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-1 rat prostate tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Genistein and daidzein downregulate prostate androgen-regulated transcript-1 (PART-1) gene expression induced by dihydrotestosterone in human prostate LNCaP cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Lycopene inhibits the growth of normal human prostate epithelial cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0072

7 January 2021

Identifiers

DOI

10.1038/NCPURO0072

1 reference

13 August 2017

1 reference

PubMed ID

16474573